Targeted, non-viral gene delivery for cancer gene therapy

Related Experiment Video

Updated: Oct 13, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

R J Cristiano1

  • 1Section of Thoracic Molecular Oncology, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 109, Houston, Texas 77030, USA. rcristia@notes.mdacc.tmc.edu

Frontiers in Bioscience : a Journal and Virtual Library
|November 20, 1998
PubMed

Insights

Molecular conjugates offer targeted cancer therapy by linking DNA-binding agents to cell-specific ligands. While effective in vitro, in vivo delivery challenges persist, necessitating further research for improved gene therapy strategies.

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Targeted delivery of therapeutics to cancer cells is a significant challenge in cancer treatment and gene therapy.
  • Molecular conjugates, utilizing DNA-binding agents and cell-specific ligands, were developed to overcome these delivery hurdles.

Purpose of the Study:

  • To review the current status and future potential of molecular conjugates as targeting vectors in gene therapy.
  • To discuss the advantages and disadvantages of molecular conjugates compared to other viral and non-viral vectors.

Main Methods:

  • Review of existing literature on molecular conjugates for targeted gene delivery.
  • Analysis of various ligands used in molecular conjugate design.
  • Comparison of in vitro and in vivo delivery efficiencies.

Main Results:

  • Molecular conjugates demonstrate efficient in vitro targeting but face limited in vivo delivery.
  • Challenges include endosomal escape and vector complexity.
  • Various ligands have been explored, with varying degrees of success.

Conclusions:

  • Molecular conjugates hold promise for targeted cancer therapy and gene delivery.
  • Overcoming in vivo limitations, such as endosomal entrapment, is crucial for clinical translation.
  • Further development is needed to optimize these synthetic vectors for effective gene therapy strategies.

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...